Proteomic Analysis Identifies NDUFS1 and ATP5O as Novel Markers for Survival Outcome in Prostate Cancer
Simple Summary
- Supplementary File 1:
ZIP-Document (ZIP, 69 KiB)
Wiebringhaus, R.; Pecoraro, M.; Neubauer, H.A.; Trachtová, K.; Trimmel, B.; Wieselberg, M.; Pencik, J.; Egger, G.; Krall, C.; Moriggl, R.; Mann, M.; Hantusch, B.; Kenner, L. Proteomic Analysis Identifies NDUFS1 and ATP5O as Novel Markers for Survival Outcome in Prostate Cancer. Cancers 2021, 13, 6036. https://doi.org/10.3390/cancers13236036
Wiebringhaus R, Pecoraro M, Neubauer HA, Trachtová K, Trimmel B, Wieselberg M, Pencik J, Egger G, Krall C, Moriggl R, Mann M, Hantusch B, Kenner L. Proteomic Analysis Identifies NDUFS1 and ATP5O as Novel Markers for Survival Outcome in Prostate Cancer. Cancers. 2021; 13(23):6036. https://doi.org/10.3390/cancers13236036
Chicago/Turabian StyleWiebringhaus, Robert, Matteo Pecoraro, Heidi A. Neubauer, Karolína Trachtová, Bettina Trimmel, Maritta Wieselberg, Jan Pencik, Gerda Egger, Christoph Krall, Richard Moriggl, Matthias Mann, Brigitte Hantusch, and Lukas Kenner. 2021. "Proteomic Analysis Identifies NDUFS1 and ATP5O as Novel Markers for Survival Outcome in Prostate Cancer" Cancers 13, no. 23: 6036. https://doi.org/10.3390/cancers13236036